Cross-source identity
National Provider Identifier 1205333887 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|
| CMS NPPES | NPI 1205333887 | Registry identity — dermatologist, taxonomy 207N00000X | Source:CMS NPPESSnapshot 2026-05-06 |
| CMS Open Payments | NPI 1205333887 | 363 industry-payment records, 2024 | Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1205333887 | 11 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $135,727 | 48 |
| Consulting Fee | $43,792 | 17 |
| Travel and Lodging | $13,280 | 53 |
| Food and Beverage | $12,196 | 244 |
| Education |
| Manufacturer | Amount | Records |
|---|---|---|
| Amgen Inc. | $71,299 | 78 |
| Janssen Biotech, Inc. | $31,876 | 47 |
| Galderma Laboratories, L.P. | $24,319 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Tremfya(Guselkumab) | 15 | $218,453 |
| Dupixent Pen(Dupilumab) | 18 | $72,292 |
| Doxycycline Hyclate | 514 | $2,608 |
| Fluorouracil | 15 | $1,183 |
| Clobetasol Propionate | 31 | $1,111 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
| 1 |
| 24 |
| Leo Pharma Inc. | $18,752 | 33 |
| Pfizer Inc. | $12,882 | 25 |